Baltimore Washington Financial Advisors Inc. boosted its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 1.0% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 231,522 shares of the real estate investment trust’s stock after buying an additional 2,258 shares during the period. Omega Healthcare Investors makes up approximately 1.8% of Baltimore Washington Financial Advisors Inc.’s portfolio, making the stock its 24th largest position. Baltimore Washington Financial Advisors Inc. owned about 0.12% of Omega Healthcare Investors worth $7,645,000 as of its most recent SEC filing.
Several other institutional investors have also recently added to or reduced their stakes in the company. Tompkins Financial Corp bought a new position in shares of Omega Healthcare Investors during the first quarter worth about $165,000. South Texas Money Management Ltd. acquired a new stake in shares of Omega Healthcare Investors during the first quarter worth $207,000. Lodestar Investment Counsel LLC IL acquired a new stake in shares of Omega Healthcare Investors during the first quarter worth $209,000. Wesbanco Bank Inc. acquired a new stake in shares of Omega Healthcare Investors during the first quarter worth $211,000. Finally, Arete Wealth Advisors LLC acquired a new stake in shares of Omega Healthcare Investors during the first quarter worth $216,000. Institutional investors and hedge funds own 73.62% of the company’s stock.
Omega Healthcare Investors, Inc. (OHI) traded up 0.50% during mid-day trading on Friday, reaching $30.29. 1,649,936 shares of the company’s stock were exchanged. Omega Healthcare Investors, Inc. has a 52 week low of $28.11 and a 52 week high of $38.09. The stock has a 50-day moving average price of $32.54 and a 200-day moving average price of $32.55. The stock has a market cap of $5.97 billion, a P/E ratio of 15.98 and a beta of 0.50.
Omega Healthcare Investors (NYSE:OHI) last issued its earnings results on Wednesday, July 26th. The real estate investment trust reported $0.33 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.49 by $0.16. Omega Healthcare Investors had a return on equity of 8.88% and a net margin of 40.20%. The company had revenue of $194 million for the quarter, compared to the consensus estimate of $194.59 million. During the same quarter last year, the business posted $0.87 EPS. Omega Healthcare Investors’s quarterly revenue was up 4.0% on a year-over-year basis. On average, analysts forecast that Omega Healthcare Investors, Inc. will post $1.82 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, August 15th. Shareholders of record on Tuesday, August 1st will be issued a dividend of $0.64 per share. The ex-dividend date is Friday, July 28th. This represents a $2.56 dividend on an annualized basis and a yield of 8.45%. This is a boost from Omega Healthcare Investors’s previous quarterly dividend of $0.63. Omega Healthcare Investors’s dividend payout ratio (DPR) is 135.45%.
COPYRIGHT VIOLATION WARNING: This article was posted by Community Financial News and is the property of of Community Financial News. If you are reading this article on another domain, it was stolen and republished in violation of U.S. & international copyright and trademark laws. The original version of this article can be accessed at https://www.com-unik.info/2017/08/12/baltimore-washington-financial-advisors-inc-has-7-65-million-position-in-omega-healthcare-investors-inc-nyseohi-updated-updated-updated.html.
A number of equities research analysts have weighed in on OHI shares. Zacks Investment Research raised shares of Omega Healthcare Investors from a “hold” rating to a “buy” rating and set a $39.00 price target for the company in a report on Wednesday, April 19th. BidaskClub downgraded shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a report on Saturday, August 5th. Vetr downgraded shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating and set a $32.50 price target for the company. in a report on Monday, April 17th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and set a $33.00 price objective on shares of Omega Healthcare Investors in a research note on Friday, May 12th. Two equities research analysts have rated the stock with a sell rating and five have assigned a hold rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $34.38.
In other news, CFO Robert O. Stephenson sold 23,000 shares of Omega Healthcare Investors stock in a transaction dated Wednesday, June 28th. The stock was sold at an average price of $34.58, for a total transaction of $795,340.00. Following the transaction, the chief financial officer now owns 68,978 shares in the company, valued at approximately $2,385,259.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Craig R. Callen acquired 15,000 shares of the business’s stock in a transaction dated Friday, June 2nd. The shares were acquired at an average price of $31.40 per share, for a total transaction of $471,000.00. Following the acquisition, the director now directly owns 18,000 shares in the company, valued at $565,200. The disclosure for this purchase can be found here. 4.54% of the stock is currently owned by company insiders.
About Omega Healthcare Investors
Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.
What are top analysts saying about Omega Healthcare Investors Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Omega Healthcare Investors Inc. and related companies.